Abbott Laboratories (ABT)
Debt-to-assets ratio
Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
---|---|---|---|---|---|---|
Long-term debt | US$ in thousands | — | — | — | — | — |
Total assets | US$ in thousands | 81,414,000 | 73,214,000 | 74,438,000 | 75,196,000 | 72,548,000 |
Debt-to-assets ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-assets ratio = Long-term debt ÷ Total assets
= $—K ÷ $81,414,000K
= 0.00
The debt-to-assets ratio for Abbott Laboratories has consistently remained at 0.00 from December 31, 2020, to December 31, 2024. A debt-to-assets ratio of 0.00 indicates that Abbott Laboratories has not financed its assets with debt during this period. This could suggest that the company has a strong financial position and may be relying more on equity financing or have minimal debt obligations compared to its total assets. However, it is important to consider other factors such as the cost of capital and the overall financial health of the company when evaluating its debt management and financial stability.
Peer comparison
Dec 31, 2024